Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial (Q43774257)
Jump to navigation
Jump to search
scientific article published on 4 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial |
scientific article published on 4 January 2010 |
Statements
1 reference
Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial (English)
1 reference
1 reference
Dirk Schadendorf
1 reference
Axel Hauschild
1 reference
Michael Weichenthal
1 reference
Knuth Rass
1 reference
Ruthild Linse
1 reference
Carola Berking
1 reference
Jörg Böttjer
1 reference
Thomas Vogt
1 reference
Konstanze Spieth
1 reference
Norbert H Brockmeyer
1 reference
Annette Stein
1 reference
Helmut Näher
1 reference
Peter Mohr
1 reference
Martin Kaatz
1 reference
Michael Tronnier
1 reference
Rüdiger Hein
1 reference
Gerold Schuler
1 reference
Friederike Egberts
1 reference
Claus Garbe
1 reference
4 January 2010
1 reference
1 reference
28
1 reference
5
1 reference
841-846
1 reference
Identifiers
1 reference
1 reference